BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 29
• 30

• Press Releases

  AvenCell Therapeutics Announces IND Clearance and EMA Approval of Clinical Trial Application (CTA) for the QUADvance Study, a Phase I/II trial evaluating AVC-203, a Novel Allogeneic CD19/CD20 CAR-T Investigational Therapy for the Treatment of Relapsed/Refractory B-cell malignancies

  December 4, 2025

   · 

  5 min read
• Press Releases

  Evotec-Partner Bayer Starts Phase 2 Study for Treatment of Patients with Alport Syndrome

  December 4, 2025

   · 

  6 min read
• Press Releases

  Denali Therapeutics and Royalty Pharma Announce $275 Million Royalty Funding Agreement

  December 4, 2025

   · 

  8 min read
• Press Releases

  Merakris Therapeutics Announces Completion of Type C Meeting with FDA – Alignment on MTX-001 Biologic Drug Development Pathway

  December 4, 2025

   · 

  4 min read
• PreciseDxⓇ Presents New Data for PreciseBreastⓇ, an AI Digital Pathology Test to Predict Breast Cancer Recurrence, at the 2025 San Antonio Breast Cancer Symposium

  December 4, 2025

   · 

  2 min read
• Press Releases

  RadioMedix and Thor Medical enter supply agreement for thorium-228

  December 4, 2025

   · 

  2 min read
• Press Releases

  BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 4, 2025

  December 4, 2025

   · 

  1 min read
• Press Releases

  Pliant Therapeutics Announces Interim Data from PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors

  December 4, 2025

   · 

  8 min read
• Press Releases

  Syncromune®, Inc. Presents Phase 1 Data Highlighting Resolution of Bone Metastases in Metastatic Prostate Cancer Patients at Society of Urological Oncology 26th Annual Meeting

  December 4, 2025

   · 

  7 min read
• Press Releases

  Remedy Plan Therapeutics to Present Results from Phase 1 Healthy Volunteer Study of NAMPT Inhibitor RPT1G and Other Progress at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition

  December 4, 2025

   · 

  5 min read